Successful treatment of heart failure with devices requires collaboration

Karl Swedberg1, John Cleland, Martin R Cowie

  • 1Department of Emergency and Cardiovascular Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. karl.swedberg@gu.se

Insights

Implanted cardiac resynchronisation therapy (CRT) and implantable cardioverter defibrillators (ICD) improve outcomes in heart failure patients. Underuse persists due to guideline adherence issues, necessitating improved collaboration and education for better patient care.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Cardiac resynchronisation therapy (CRT) and implantable cardioverter defibrillators (ICDs) are proven to enhance survival and reduce morbidity in select chronic heart failure (CHF) patients.
  • Evidence for device therapy in specific subgroups, like NYHA Class I or IV heart failure with reduced ejection fraction, or modest QRS prolongation, remains limited.
  • Despite established benefits, a significant gap exists between eligible patients and those receiving these life-saving device therapies.

Purpose of the Study:

  • To highlight the underutilization of CRT and ICDs in chronic heart failure (CHF) management.
  • To identify barriers to device therapy adoption, including healthcare professional adherence to guidelines.
  • To advocate for improved collaboration among specialists and structured approaches to optimize device therapy delivery.

Main Methods:

  • Review of current evidence on CRT and ICD efficacy in chronic heart failure (CHF).
  • Analysis of reasons for underuse of device therapies in eligible patient populations.
  • Discussion of strategies to improve guideline adherence and patient access to device therapy.

Main Results:

  • CRT and ICDs offer survival and morbidity benefits for specific CHF patient groups.
  • Limited evidence exists for device therapy in certain patient subgroups, contributing to hesitancy.
  • A minority of eligible CHF patients currently receive recommended device therapies, indicating underuse.

Conclusions:

  • Underuse of CRT and ICDs in CHF is a significant issue, partly due to poor guideline adherence.
  • Enhanced collaboration between heart failure specialists, electrophysiologists, and primary care physicians is crucial.
  • A structured, collaborative approach is needed to improve care, reduce mortality and morbidity, and increase cost-effectiveness.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...